Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Sales | 125,860 | 108,651 | 99,102 | 303,992 | 153,082 |
| Cost of Goods | 66,158 | 50,114 | 48,657 | 143,121 | 68,892 |
| Gross Profit | 59,702 | 58,537 | 50,445 | 160,871 | 84,190 |
| Operating Expenses | 41,854 | 37,957 | 41,409 | 37,632 | 35,788 |
| Operating Income | 18,006 | 20,694 | 9,693 | 123,360 | 49,294 |
| Interest Expense | 11 | 16 | 59 | 38 | 23 |
| Other Income | -255 | 324 | 175 | 314 | 167 |
| Pre-tax Income | 17,740 | 21,002 | 9,809 | 123,636 | 49,438 |
| Income Tax | 5,214 | 7,144 | -2,594 | 48,501 | 18,130 |
| Net Income Continuous | 12,526 | 13,858 | 12,403 | 75,135 | 31,308 |
| Minority Interests | -24 | 5 | -19 | -28 | -40 |
| Net Income | $12,550 | $13,853 | $12,422 | $75,163 | $31,348 |
| EPS Basic Total Ops | 0.20 | 0.22 | 0.20 | 1.20 | 0.51 |
| EPS Basic Continuous Ops | 0.20 | 0.22 | 0.20 | 1.20 | 0.51 |
| EPS Diluted Total Ops | 0.19 | 0.21 | 0.19 | 1.15 | 0.48 |
| EPS Diluted Continuous Ops | 0.19 | 0.21 | 0.19 | 1.15 | 0.48 |
| EBITDA(a) | $23,564 | $25,513 | $15,178 | $223,679 | $57,592 |